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Abstract
Background: The genetic diversity of Plasmodium falciparum has been extensively studied in
various parts of the world. However, limited data are available from Pakistan. This study aimed to
establish molecular characterization of P. falciparum field isolates in Pakistan measured with two
highly polymorphic genetic markers, i.e. the merozoite surface protein 1 (msp-1)and 2 (msp-2).
Methods: Between October 2005 and October 2007, 244 blood samples from patients with
symptomatic blood-slide confirmed P. falciparum mono-infections attending the Aga Khan
University Hospital, Karachi, or its collection units located in Sindh and Baluchistan provinces,
Pakistan were collected. The genetic diversity of P. falciparum was analysed by length polymorphism
following gel electrophoresis of DNA products from nested polymerase chain reactions (PCR)
targeting block 2 of msp-1 and block 3 of msp-2, including their respective allelic families KI, MAD
20, RO33, and FC27, 3D7/IC.
Results: A total of 238/244 (98%) patients had a positive PCR outcome in at least one genetic
marker; the remaining six were excluded from analysis. A majority of patients had monoclonal
infections. Only 56/231 (24%) and 51/236 (22%) carried multiple P. falciparum genotypes in msp-1
and msp-2, respectively. The estimated total number of genotypes was 25 msp-1 (12 KI; 8 MAD20;
5 RO33) and 33 msp-2 (14 FC27; 19 3D7/IC).
Conclusions: This is the first report on molecular characterization of P. falciparum field isolates in
Pakistan with regards to multiplicity of infection. The genetic diversity and allelic distribution found
in this study is similar to previous reports from India and Southeast Asian countries with low
malaria endemicity.
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Plasmodium falciparum is an important public health prob-
lem in Pakistan causing at least 500,000 cases of malaria
annually [1]. An increasing number of cases are being
reported every year and the relative frequency of P. falci-
parum amongst slide positive malaria cases has increased
from 45% in 1995 to 68% in 2006 [2-4]. In line with this,
the National Malaria Control Programme has reported a
six-fold increase in P. falciparum during the last decade.
Despite this malaria has received scarce scientific atten-
tion, particularity with regards to molecular characteriza-
tion of the local parasite population.
The introduction of PCR genotyping in malaria research
has paved the way for major improvements in the under-
standing of parasite biology. For example, a number of
highly diverse genetic markers of P. falciparum have been
identified and extensively studied as potential vaccine
candidates [5,6]. The most commonly used markers for
genotyping of P. falciparum are the surface antigens mero-
zoite surface protein 1 (msp-1), merozoite surface protein 2
(msp-2) and the glutamate-rich protein (glurp) [7,8]. These
three genetic markers are unlinked, i.e. located on differ-
ent chromosomes, single copy genes with extensive poly-
morphism, both with regards to sequence and size, which
is mostly generated by intragenic repeats that are variable
in copy number and length of the repeat unit [9]. These
features make them attractive candidates for studies where
identification and enumeration of genetically distinct P.
falciparum parasite sub-populations are of interest. As such
they have proven to be useful tools both in molecular epi-
demiology studies in different epidemiological settings as
well as to distinguish treatment failures from new infec-
tions in anti-malarial drug trials [10,11].
The genetic diversity among the P. falciparum population
is an important indicator of the malaria transmission
intensity in an area [12,13]. A high endemic area is gener-
ally characterized by extensive parasite diversity and
infected humans often carry multiple genotypes. Con-
versely, the parasite population in a low transmission area
has a limited genetic diversity and the majority of infec-
tions are monoclonal [14-17].
Plasmodium falciparum field isolates have been character-
ized in both Iran and India, but not previously in Paki-
stan, using the above mentioned molecular markers. This
study, therefore, aimed to bridge this gap by molecular
characterization of P. falciparum field isolates in Pakistan
measured using two highly polymorphic markers, i.e. msp-
1 and msp-2.
Methods
Study setting, participants, and ethics
Between October 2005 and October 2007, patients of all
ages presenting with microscopy confirmed asexual P. fal-
ciparum mono-infections, regardless of parasite density
and disease severity, at the Aga Khan University Hospital,
Karachi or its established chain of health centres/collec-
tion units located in Sindh and Baluchistan provinces,
Pakistan were enrolled in this study.
The study was conducted in accordance with the latest ver-
sion of the Declaration of Helsinki and Good Clinical
Practice [18]. Informed consent was obtained from all
participants or in case of children from their parents/legal
guardians. The study was approved by the ethical review
committee of Aga University Hospital, Karachi, Pakistan.
Blood collection and microscopy
An intravenous blood sample of 2 ml was collected in an
EDTA tube in accordance with routine clinical practice for
all patients referred for laboratory investigation of malaria
infection. Initially, a blood smear was microscopically
analysed using Leishman staining for screening of pres-
ence of malaria parasites [19]. In case of a positive screen-
ing slide a confirmatory thick and thin Giemsa-stained
blood film was analysed for species identification and
parasite density. For patients with confirmed P. falciparum
mono-infection asexual parasites were counted against
200 white blood cells on the thick film. Parasite density
was quantified (parasites/μl) by assuming an average of
8,000 leucocytes per μl blood [20]. All blood slides were
examined by experienced microscopists at the clinical lab-
oratory, Aga Khan University. Quality control was done
for 10% of the slides by an independent microscopist
blinded to the initial report.
For all patients enrolled in the study the remaining blood
volume collected in the EDTA tube was transferred to cry-
ovials and kept frozen at -80°C until used for DNA extrac-
tion. A brief epidemiological/demographic history was
also collected from each participant using a structured
questionnaire.
DNA extraction and molecular analyses
Genomic DNA was extracted from a total of 200 μl whole
blood per patient using the Qiagen DNA extraction kit
(QIAGEN, USA) according to manufacturer's instructions.
Nested PCR genotyping was performed both for the vari-
able block 2 regions of msp-1 and block 3 of msp-2, con-
sidered to be the two most informative genetic markers for
assessment of multiplicity of P. falciparum infection [9].
The initial amplification was followed by individual
nested PCR reactions using family specific primers for
msp-1 (KI, MAD20 and R033), and msp-2 (FC27 and 3D7/
IC), respectively, based on previously described standard
protocols [21]. Positive and negative controls were sys-
tematically incorporated in each PCR run. The msp-1 and
msp-2 PCR products were loaded on 3% and 2% agarose
gels, respectively, stained with ethidium-bromide, sepa-Page 2 of 6
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illumination (GelDoc®, Biorad, Hercules, USA).
Analyses of number of genotypes and size polymorphism
were digitalized using Quantity One® software (Biorad,
Hercules, USA). For assessment of the overall number of
genotypes present within the P. falciparum population and
their respective prevalence, individual genotypes were
defined arbitrarily by binning 20 base-pair (bp) intervals
together. The median genotype for each family of the
respective genetic markers was identified. The absolute
size of the identified median band +/- 10 bp formed the
initial bin. Thereafter, each 20 bp interval below and
above the median band were defined as representing a
distinct genotype.
Study design and statistical analyses
This was a descriptive/exploratory study, which precludes
a power calculation of sample size. Data were entered in
Microsoft Excel and exported to SPSS 15.0 software for
analyses. Arithmetical means and medians, where appli-
cable, were calculated for all continuous baseline demo-
graphic variables, except for asexual parasite density
(geometric mean). Proportions of binary outcomes were
compared using non-parametric tests. Spearman's rank
correlation coefficients were calculated to assess associa-
tion between multiplicity of infection and parasite densi-
ties. Statistical significance was defined as a P value ≤ 0.05.
Results
Baseline demographic data
A total of 244 patients with microscopy confirmed P. fal-
ciparum mono-infection were enrolled. Six (2.5%) were
excluded from the analysis due to negative PCR outcome
in both the msp-1 and msp-2 marker. The remaining 238
patients all presented with symptomatic malaria infec-
tion, 164 (69%) with uncomplicated and the remaining
74 (31%) with complicated/severe disease.
The geographical distribution of the 238 patients included
in the analysis was: 176 (74%) from Karachi, 21 (9%)
from Sukkur, 31 (13%) from rural areas of Sindh province
and the remaining 10 (4%) from Baluchistan. The asexual
P. falciparum parasitaemia ranged from 50 to 500,000 par-
asites/μl with a geometric mean of 8,412 parasites/μl.
Plasmodium falciparum allelic diversity
Length polymorphism was assessed in 238 P. falciparum
field isolates within the allelic families of msp-1 and msp-
2, with a total of 289 distinct fragments detected, repre-
senting an estimated 25 msp-1 and 33 msp-2 genotypes.
The distribution of genotypes within the respective allelic
families of msp-1 and msp-2, as well as their corresponding
bp ranges is presented in Table 1. All family specific allelic
types of msp-1, i.e. MAD20, RO33 and KI, were observed
in the different geographical locations. The proportions of
MAD20, K1 and RO33 types were 46%, 26% and 14%,
respectively. Some 14% of the infections carried two
allelic types (MAD20/K1, RO33/K1, MAD20/RO33),
whereas no sample contained all three allelic types of msp-
1. The occurrence of K1 family specific alleles of msp-1
ranged from 30-65% with the highest proportion in Balu-
chistan, whereas MAD20 allelic family was detected in 20-
61% of the samples. The RO33 allelic type of msp-1, which
was observed in 20% of the samples, was comparatively
less prevalent as well as less polymorphic. For msp-2 allelic
families 44% of the infections carried FC27 type and 40%
carried 3D7/IC type, whereas 16% of the infections har-
boured both allelic types. The two allelic types of msp-2
were equally distributed with proportion of 3D7/IC and
FC27 ranging between 46-70% and 30-69%, respectively,
in isolates from different geographic locations.
Association between mean multiplicity of infection, 
parasite densities and age
The overall mean multiplicity of msp-1 and msp-2 geno-
types per infection were 1.25 (95% CI: 1.19-1.31) and
1.22 (95% CI: 1.17-1.28), respectively. The multiplicity of
infection observed in the three different geographical
areas is presented in Table 2. There was no statistical dif-
ference in multiplicity of infection in patients originating
from Karachi and Sindh (p = 0.670). However, the low
number of patients from Baluchistan (n = 10) precludes a
meaningful comparison of the diversity in this region
with the other two.
A majority of the infections were monoclonal. Only 56/
231 (24%) and 51/236 (22%) patients carried multiple P.
falciparum genotypes in msp-1 and msp-2, respectively. P.
falciparum parasite density stratified by number of msp-1
and msp-2 genotypes per infection is presented in Table 3.
Table 1: Number of Plasmodium falciparum genotypes and base pair ranges observed in msp-1 and msp-2, as well as their respective 
allelic families
msp-1 msp-2
K1 MAD20 RO33 FC27 IC
Base pair range 145-459 100-257 108-196 205-512 310-894
No. of genotypes 12 8 5 14 19
Total no. of genotypes 25 33
Overall multiplicity of infection 1.25 1.22Page 3 of 6
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icantly higher (21,210 parasites/μl) in the 56 patients car-
rying multiple msp-1 genotypes compared with the 175
patients with monoclonal infections (7,049 parasites/μl,
p < 0.001). However, no statistically significant difference
was observed between the 51 patients harbouring multi-
clonal and the 185 patients with single msp-2 genotype
infections, 10,532 versus 7,793 parasites/μl, respectively
(p = 0.519). A statistically significant correlation between
parasite density and number of genotypes was observed in
msp-1 (Spearman rank coefficient = 0.184; p = 0.005), but
not in msp-2 (p = 0.432). Parasite density and mean mul-
tiplicity of infection in msp-1 and msp-2 stratified by age is
presented in Table 4, with no statistically significant dif-
ferences observed.
Discussion
This is the first report on genetic diversity of P. falciparum
field isolates from Pakistan and as such, it bridges an
important gap in the understanding of the molecular
characteristics of the parasite population in South Asia.
The results reveal a relatively limited genetic diversity and
multiplicity of infection. These findings are compatible
with the general belief that Pakistan, despite potential
substantial regional variations and recent increases in P.
falciparum incidence, represents a low malaria transmis-
sion setting [13,14,16,22,23]. Moreover, the results are in
line with several previous reports from India, Iran and
Southeast Asian countries with low malaria transmission
[24]. In contrast, the results of this study do not corrobo-
rate recent finding from Iran where Zakeri et al reported a
relatively high multiplicity of infection in both the msp-1
and msp-2 marker from a presumably low endemic area
[21].
However, it should be emphasized that a majority of
patients (74%) presented with symptomatic malaria
infection at a tertiary level of care, i.e. the Aga Khan Uni-
versity Hospital. Consequently, some of these patients
may have received anti-malarial treatment prior to enrol-
ment in the study. As treatment is likely to reduce the
number of genotypes in an infected individual, the P. fal-
ciparum identified in these patients may not be represent-
ative for the Pakistani parasite population. Moreover,
reports of genetic diversity from low endemic areas gener-
ally study symptomatic P. falciparum infections, since
asymptomatic carriers rarely are observed in setting where
semi-immunity cannot be acquired [25]. This is of impor-
tance since data indicate that symptomatic infections gen-
erally appear to harbour a lower multiplicity of infection
as compared to asymptomatic children residing in high
transmission areas in Africa [26]. Lastly, the inability to
detect all parasite sub-populations present in an individ-
ual with one single blood sample, either due to inborn
limitations of the PCR technique to detect minority clones
or parasite population dynamics, may also be considered
as a factor potentially underestimating the multiplicity of
infection retrieved in our study [27]. Thus, the results of
this study may reflect a significant underestimation of the
genetic diversity of the P. falciparum population in Paki-
stan.
The reported study represents a first attempt to establish
molecular techniques for malaria research at the Aga Khan
University, Karachi. Future studies will be designed to
geographically expand the collection of P. falciparum field
isolates to include all four provinces of Pakistan. During
the next phase, analyses of genetic markers related to anti-
Table 2: Multiplicity of Plasmodium falciparum infection as 
assessed with the msp-1 and msp-2 marker in different 
geographic locations of Southern Pakistan







1 127 (74) 40 (77) 8 (89)
2 41 (24) 12 (23) 1 (11)
3 2 (1) 0 0
Multiplicity of infection* 1.26 1.23 1.11
msp2
1 135(77) 40 (77) 10 (100)
2 38 (22) 11 (21) 0
3 1 (0.5) 1 (2) 0
Multiplicity of infection* 1.23 1.25 1.00
* Mean multiplicity of infection
Table 3: Plasmodium falciparum parasite density stratified by number of msp-1 and msp-2 genotypes per infection.





1 166 7049 170 7793
2 48 20160 44 9721
3 2 71746 2 61399
* Only samples with positive PCR outcomes in both msp-1 and msp-2 were included.
§ Parasite densities were available form 216 patients.Page 4 of 6
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more thorough picture of P. falciparum molecular epide-
miology in Pakistan.
Conclusions
The genetic diversity and allelic distribution found in this
study is similar to previous reports from India and South-
east Asian countries with low malaria endemicity.
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